Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine for Acute Coronary Syndromes
NCT01906749Phase 4Unknown
- Sponsor
- Ospedale Maria Vittoria
- Start
- Jun 2013
- Primary completion
- Jun 2016
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute coronary syndrome (ACS) comparing Colchicine with Placebo (2 arms). Primary endpoint: Overall mortality, new acute coronary syndrome, and ischemic stroke at 24 months. Status: unknown.
02
Drugs
colchicine
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT01906749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01906749.